Optimization of a fibrin scaffold for sustained release of an adenoviral gene vector

被引:32
作者
Breen, Ailish [1 ]
Strappe, Padraig
Kumar, Anil
O'Brien, Timothy
Pandit, Abhay
机构
[1] Natl Univ Ireland Univ Coll Galway, Natl Ctr Biomed Engn Sci, Dept Mech & Biomed Engn, Galway, Ireland
[2] Natl Univ Ireland Univ Coll Galway, Regenerat Med Inst, Galway, Ireland
关键词
fibrin; biodegradable implant; drug delivery system; tissue engineering; gene transfer;
D O I
10.1002/jbm.a.30735
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
One of the major limitations of adenovirus as an efficient gene delivery vehicle is its transient nature of transgene expression. At present, no biodegradable release system exists that permits the sustained release of gene delivery. This study aimed to optimize a biodegradable fibrin scaffold for sustained adenoviral mediated gene delivery. Scaffold formulations were fabricated incorporating an adenoviral vector encoding beta-galactosidase, and each scaffold was incubated in elution fluid. The level of transfection of cells was measured to assess virus diffusion from each scaffold at different time periods. Results showed that viral particles were present in the elution fluid and had the ability to transfect cells at different time points. Depending on the scaffold formulation, variable rates of diffusion were seen. Analysis of scaffold microarchitecture using stereo pairs showed that variable pore depth is seen in different fibrin scaffold concentration, which may be a determining factor in the diffusion rate. It was concluded that sustained release of the adenovirus could be attained up to 192 h at the optimal concentration of 60 mg/mL fibrinogen and 4 IU thrombin. (c) 2006 Wiley Periodicals, Inc.
引用
收藏
页码:702 / 708
页数:7
相关论文
共 16 条
[1]   Ultrastructural basement membrane topography of the bladder epithelium [J].
Abrams, GA ;
Murphy, CJ ;
Wang, ZY ;
Nealey, PF ;
Bjorling, DE .
UROLOGICAL RESEARCH, 2003, 31 (05) :341-346
[2]   IMPROVEMENT OF TRACHEAL AUTOGRAFT REVASCULARIZATION BY MEANS OF FIBROBLAST GROWTH-FACTOR [J].
ALBES, JM ;
KLENZNER, T ;
KOTZERKE, J ;
THIEDEMANN, KU ;
SCHAFERS, H ;
BORST, HG .
ANNALS OF THORACIC SURGERY, 1994, 57 (02) :444-449
[3]   Plasmid gene delivery to human keratinocytes through a fibrin-mediated transfection system [J].
Andree, C ;
Voigt, M ;
Wenger, A ;
Erichsen, T ;
Bittner, K ;
Schaefer, D ;
Walgenbach, KJ ;
Borges, J ;
Horch, RE ;
Eriksson, E ;
Stark, B .
TISSUE ENGINEERING, 2001, 7 (06) :757-766
[4]  
Chandler LA, 2004, WOUNDS, V16, P23
[5]   Matrix-enabled gene transfer for cutaneous wound repair [J].
Chandler, LA ;
Gu, DL ;
Ma, CL ;
Gonzalez, AM ;
Doukas, J ;
Nguyen, T ;
Pierce, GF ;
Phillips, ML .
WOUND REPAIR AND REGENERATION, 2000, 8 (06) :473-479
[6]  
Chawla PS, 1999, INT ANGIOL, V18, P185
[7]   Behavior of human dermal fibroblasts in three-dimensional fibrin clots: Dependence on fibrinogen and thrombin concentration [J].
Cox, S ;
Cole, M ;
Tawil, B .
TISSUE ENGINEERING, 2004, 10 (5-6) :942-954
[8]   Adenovirus encoding human platelet-derived growth factor-B delivered in collagen exhibits safety, biodistribution, and immunogenicity profiles favorable for clinical use [J].
Gu, DL ;
Nguyen, T ;
Gonzalez, AM ;
Printz, MA ;
Pierce, GF ;
Sosnowski, BA ;
Phillips, ML ;
Chandler, LA .
MOLECULAR THERAPY, 2004, 9 (05) :699-711
[9]   Fibrin sealants in surgical practice: An overview [J].
Jackson, MR .
AMERICAN JOURNAL OF SURGERY, 2001, 182 (02) :1S-7S
[10]   Fibrin encapsulated liposomes as protein delivery system - Studies on the in vitro release behavior [J].
Meyenburg, S ;
Lilie, H ;
Panzner, S ;
Rudolph, R .
JOURNAL OF CONTROLLED RELEASE, 2000, 69 (01) :159-168